Association of serum c-reactive protein and erythrocyte sedimentation rate with muscle strength in patients with knee osteoarthritis

Rheumatology (United Kingdom)

Volumn 52, Issue 4, 2013, Pages 727-732

  Sanchez ramirez, Diana C ^a,b,c   Van der leeden, Marike ^a,c   Van der esch, Martin ^a   Gerritsen, Martijn ^d   Roorda, Leo D ^a   Verschueren, Sabine ^e   Van dieën, Jaap ^b   Dekker, Joost ^a,c   Lems, Willem F ^c,d  

^a Amsterdam Rehabilitation Research Centre Reade Amsterdam Reade   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Jan Van Breemen Research Institute/Reade   (Netherlands)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

C reactive protein; Erythrocyte sedimentation rate; Inflammatory markers; Knee osteoarthritis; Muscle strength

Indexed keywords

C REACTIVE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DRUG USE; DYNAMOMETER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HAMSTRING; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUADRICEPS FEMORIS MUSCLE; SEX DIFFERENCE;

AGED; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MUSCLE STRENGTH; OSTEOARTHRITIS, KNEE; QUADRICEPS MUSCLE; REGRESSION ANALYSIS;

EID: 84875606400     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes366     Document Type: Article

References (44)

1. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011; 377:2115_26.
2. O'Reilly SC, Jones A, Muir KR, Doherty M. Quadriceps weakness in knee osteoarthritis: the effect on pain and disability. Ann Rheum Dis 1998;57:588_94.
3. Konttinen YT, Sillat T, Barreto G, Ainola M, Nordstrom DC. Osteoarthritis as an autoinflammatory disease caused by chondrocyte-mediated inflammatory responses. Arthritis Rheum 2012;64:613_6.
4. Saxne T, Lindell M, Mansson B, Petersson IF, Heinegard D. Inflammation is a feature of the disease process in early knee joint osteoarthritis. Rheumatology 2003;42:903_4.
5. Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997;24:365_71.
6. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237_47.
7. Sharif M, Elson CJ, Dieppe PA, Kirwan JR. Elevated serum C-reactive protein levels in osteoarthritis. Br J Rheumatol 1997;36:140_1.
8. Sipe JD. Acute-phase proteins in osteoarthritis. Semin Arthritis Rheum 1995;25:75_86.
9. Spector TD, Hart DJ, Nandra D et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997;40:723_7.
10. Wolfe F. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J Rheumatol 1997;24:1486_8.
11. Pearle AD, Scanzello CR, George S et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007; 15:516_23.
12. Penninx BW, Abbas H, Ambrosius W et al. Inflammatory markers and physical function among older adults with knee osteoarthritis. J Rheumatol 2004;31:2027_31.
13. Sturmer T, Brenner H, Koenig W, Gunther KP. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 2004;63:200_5.
14. Schiottz-Christensen B, Lyngberg K, Keiding N, Ebling AH, Danneskiold-Samsoe B, Bartels EM. Use of isokinetic muscle strength as a measure of severity of rheumatoid arthritis: a comparison of this assessment method for RA with other assessment methods for the disease. Clin Rheumatol 2001;20:423_7.
15. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006;119:526_17.
16. Visser M, Pahor M, Taaffe DR et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57: M326_32.
17. Schaap LA, Pluijm SM, Deeg DJ et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009;64:1183_9.
18. Franceschi C, Capri M, Monti D et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007;128:92_105.
19. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol 2005;98:911_7.
20. Levinger I, Levinger P, Trenerry MK et al. Increased inflammatory cytokine expression in the vastus lateralis of patients with knee osteoarthritis. Arthritis Rheum 2011;63: 1343_8.
21. Santos ML, Gomes WF, Pereira DS et al. Muscle strength, muscle balance, physical function and plasma interleukin-6 (IL-6) levels in elderly women with knee osteoarthritis (OA). Arch Gerontol Geriatr 2011;52:322_6.
22. Altman R, Asch E, Bloch D et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29: 1039_49.
23. Knoop J, van der Leeden M, van der Esch M et al. Association of lower muscle strength with self-reported knee instability in osteoarthritis of the knee: results from the Amsterdam Osteoarthritis Cohort. Arthritis Care Res 2012;64:38_45.
24. Altman R, Alarcon G, Appelrouth D et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34:505_14.
25. Price CP, Trull AK, Berry D, Gorman EG. Development and validation of a particle-enhanced turbidimetric immunoassay for C-reactive protein. J Immunol Methods 1987;99: 205_11.
26. Senju O, Takagi Y, Uzawa R et al. A new immuno quantitative method by latex agglutination_application for the determination of serum C-reactive protein (CRP) and its clinical significance. J Clin Lab Immunol 1986;19:99_103.
27. Patton WN, Meyer PJ, Stuart J. Evaluation of sealed vacuum extraction method (Seditainer) for measurement of erythrocyte sedimentation rate. J Clin Pathol 1989;42: 313_7.
28. van der Esch M, Steultjens M, Harlaar J, Knol D, Lems W, Dekker J. Joint proprioception, muscle strength, and functional ability in patients with osteoarthritis of the knee. Arthritis Rheum 2007;57:787_93.
29. van der Esch M, Koop J, van der Leeden M et al. Selfreported knee instability and activity limitations in patients with knee osteoarthritis: results of the Amsterdam osteoarthritis cohort. Clin Rheumatol 2012;31:1505_10.
30. Kean CO, Birmingham TB, Garland SJ, Bryant DM, Giffin JR. Minimal detectable change in quadriceps strength and voluntary muscle activation in patients with knee osteoarthritis. Arch Phys Med Rehabil 2010;91: 1447_51.
31. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 2004;16:622_6.
32. Engstrom G, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Lohmander LS. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage 2009;17:168_73.
33. Beenakker KG, Ling CH, Meskers CG et al. Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev 2010;9:431_6.
34. Ferrucci L, Penninx BW, Volpato S et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2012;50:1947_54.
35. Goodman MN. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 1991;260: E727_30.
36. Goodman MN. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 1994; 205:182_5.
37. Bodell PW, Kodesh E, Haddad F, Zaldivar FP, Cooper DM, Adams GR. Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J Appl Physiol 2009;106:443_53.
38. Conde J, Scotece M, Gomez R, Lopez V, Gomez-Reino JJ, Gualillo O. Adipokines and osteoarthritis: novel molecules involved in the pathogenesis and progression of disease. Arthritis 2011;2011:203901.
39. Rai MF, Sandell LJ. Inflammatory mediators: tracing links between obesity and osteoarthritis. Crit Rev Eukaryot Gene Expr 2011;21:131_42.
40. Miller GD, Nicklas BJ, Loeser RF. Inflammatory biomarkers and physical function in older, obese adults with knee pain and self-reported osteoarthritis after intensive weight-loss therapy. J Am Geriatr Soc 2008;56:644_51.
41. Yeh ET. A new perspective on the biology of C-reactive protein. Circ Res 2005;97:609_11.
42. Kerkhof HJ, Bierma-Zeinstra SM, Castano-Betancourt MC et al. Serum C reactive protein levels and genetic variation in the CRP gene are not associated with the prevalence, incidence or progression of osteoarthritis independent of body mass index. Ann Rheum Dis 2010; 69:1976_82.
43. Sowers M, Jannausch M, Stein E, Jamadar D, Hochberg M, Lachance L. C-reactive protein as a biomarker of emergent osteoarthritis. Osteoarthritis Cartilage 2002;10:595_601.
44. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005;45: 1563_9.